We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Gaining Weight between Pregnancies Boosts Diabetes Risk

By HospiMedica International staff writers
Posted on 17 Aug 2017
Print article
Image: A new study suggests gaining weight between pregnancies elevates diabetes risk (Photo courtesy of the CDC).
Image: A new study suggests gaining weight between pregnancies elevates diabetes risk (Photo courtesy of the CDC).
A new study suggests that women who gain weight between two pregnancies have a higher risk of developing gestational diabetes mellitus (GDM).

Researchers at the University of Bergen (Norway) conducted an observational cohort study that included 24,198 mothers and data on their two first pregnancies from the Medical Birth Registry of Norway (2006–2014). Weight change, defined as pre-pregnant body mass index (BMI) in the second pregnancy minus pre-pregnant BMI in first pregnancy, was divided into six categories. Relative risk (RR) estimates were then calculated for maternal age at second delivery, country of birth, education, smoking in pregnancy, inter-pregnancy interval, and year of second birth.

The results revealed that compared to women with stable BMI, women who gained weight between the pregnancies had higher risk of GDM. The RR for women gaining 1 to 2 BMI units was 2.0; for women gaining 2 to 4 units, RR rose to 2.6, and for women who gained over 4 BMI units, RR climbed to 5.4. RR increased significantly for women with BMI both below and above 25 at first pregnancy, although it increased more for the former group. The study was published on August 1, 2017, in PLOS Medicine.

“Women who were overweight at first pregnancy had the highest risk of GDM. However, the strongest risk associated with weight gain between pregnancies was found in women with BMI less than 25 in first pregnancy,” said lead author Linn Marie Sørbye, MSc, of the Department of Global Public Health and Primary Care. “Surprisingly, we found a preventive effect of GDM in overweight women who reduced their BMI more than two units from first to second pregnancy.”

GDM is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition applies whether insulin or only diet modification is used for treatment, and whether or not the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated or begun concomitantly with the pregnancy. Approximately 7% of all pregnancies are complicated by GDM, with a prevalence of 1-14% that depends on the population studied and the diagnostic tests employed.

Related Links:
University of Bergen

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Oxidized Zirconium Implant Material
OXINIUM

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more